Back to results
US 2006/0079680 A1Published application
Pyrazoloazepine compounds as pharmaceutical agents
AssigneeEli Lilly and Company Patent Division
InventorJason Sawyer
Life of this patent
Estimating the term…
Abstract
The disclosed invention relates to compounds of the formula (I), and the pharmaceutically acceptable salts thereof.
Claims5
1-3. (canceled)
A compound of the formula:
- wherein
- R1 is hydrogen or methyl;
- Ra is hydroxy;
- (C1-C4)alkoxy;
- or —O(CH2)2N-morpholino;
- and the pharmaceutically acceptable salts thereof.
3 more elements
A method of treating cancer, fibrosis, restenosis, wound healing, HIV infection, alzheimers' disease and/or atherosclerosis comprising administering to a patient in need thereof a compound of the formula:
- wherein
- R1 is hydrogen or methyl;
- Ra is hydroxy;
- (C1-C4)alkoxy;
- or —(CH2)2N-morpholino;
- and the pharmaceutically acceptable salts thereof.
3 more elements
A pharmaceutical formulation comprising a compound of the formula:
- wherein
- R1 is hydrogen or methyl;
- Ra is hydroxy;
- (C1-C4)alkoxy;
- or —O(CH2)2N-morpholino;
- and the pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable diluent, carrier, or excipient.
3 more elements
Dependencies are inferred from the claim text.